Ironshore Employee Directory
Pharmaceutical ManufacturingUnited States51-200 Employees
Ironshore Pharmaceuticals Inc. is a United States-based pharmaceutical manufacturer. In June 2019, it launched JORNAY PM, an extended-release methylphenidate formulation for treating ADHD in patients six years of age and older. JORNAY PM is used to treat ADHD symptoms in patients. The company has pursued partnerships to broaden access, including a supply and distribution agreement with Knight Therapeutics for Canada and Latin America. In 2024, Ironshore Pharmaceuticals became part of Collegium Pharmaceutical, Inc., reflecting its integration into a larger organization.